Edition:
United States

Medical Equipment, Supplies & Distribution

Page 1

BRIEF-Semler Scientific reports Q3 loss per share of $0.07 (Oct. 28)

Friday, 4 Nov 2016 10:51am EDT

Corrects loss per share figure in headline and second bullet to $0.07 from $0.46.Semler Scientific Inc : Semler reports third quarter and year-to-date 2016 financial results . Q3 loss per share $0.07 .Q3 revenue $5.118 million versus $4.067 million.

Alliqua Biomedical reports Q3 GAAP loss per share $0.30

Friday, 4 Nov 2016 07:00am EDT

Alliqua Biomedical Inc : Reports third quarter and nine-months fiscal year 2016 financial results . Q3 non-GAAP loss per share $0.16 from continuing operations . Q3 GAAP loss per share $0.30 . Q3 revenue $4.9 million versus I/B/E/S view $4.8 million . Sees FY 2016 revenue $18.3 million to $19 million . Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $-0.74, revenue view $18.7 million -- Thomson Reuters I/B/E/S.

FDA says Heartware Inc recalling HVAD pumps due to design problem with driveline connector

Tuesday, 25 Oct 2016 08:59am EDT

U.S. Food and Drug Administration: Heartware Inc recalling the HVAD pumps due to a design problem with the driveline connector .contamination of Heartware's driveline may result in fluid or other material entering pump, causing electrical issues or pump stops.

Baxter Q3 adj earnings per share $0.56 from continuing operations excluding items

Tuesday, 25 Oct 2016 07:00am EDT

Baxter International Inc : Baxter reports third quarter 2016 results and increases financial outlook for full-year 2016 . Sees Q4 2016 earnings per share $0.49 to $0.52 from continuing operations excluding items . Q3 GAAP earnings per share $0.23 from continuing operations . Q3 sales $2.6 billion versus i/b/e/s view $2.55 billion . Q3 earnings per share view $0.45 -- Thomson Reuters I/B/E/S . Raises FY 2016 earnings per share view to $1.88 to $1.91 from continuing operations excluding items . Q3 adjusted earnings per share $0.56 from continuing operations excluding items . Sees Q4 sales up about 2 percent . Baxter international inc - raising its financial outlook for full-year 2016 including sales growth of approximately 2 percent on a reported basis . Fy2016 earnings per share view $1.72, revenue view $10.15 billion -- Thomson Reuters I/B/E/S . Sees earnings from continuing operations, before special items, of $1.88 to $1.91 per diluted share for full year . Fy2016 earnings per share view $1.72 -- Thomson Reuters I/B/E/S . Baxter International Inc - on an adjusted basis Baxter's Q3 income from continuing operations totaled $0.56 per diluted share .Baxter International Inc - for Q4, company expects sales growth of approximately 2 percent on both a reported and constant currency basis.

Ningbo Medicalsystem Biotechnology plans to divest stake in two health management units

Monday, 17 Oct 2016 05:28am EDT

Ningbo Medicalsystem Biotechnology Co Ltd <300439.SZ> : Says co plans to transfer 51 percent stake of shares in a Jinhua-based health management unit and 61 percent stake of shares in a Yongcheng-based health management unit, to co's chairman and actual controller Zou Bingde, for free .Says co will hold no stake in two units after transaction.

Bactiguard wins tender for urinary catheters covering two counties

Monday, 17 Oct 2016 02:00am EDT

Bactiguard Holding AB : Continues cooperation with Swedish counties Kronoberg and Blekinge . Won tender for urinary catheters covering counties .Contract is extension of previous agreement for 2 (+2) years.

Jiang Xi Sanxin Medtec sees 2016 9-mth net profit down 0 pct to 15 pct

Sunday, 16 Oct 2016 11:02pm EDT

Jiang Xi Sanxin Medtec Co., Ltd.<300453.SZ>: Sees net profit for 2016 Q1-Q3 to decrease by 0 percent to 15 percent, or to be 30.4 million yuan to 35.7 million yuan .Says the net profit of 2015 Q1-Q3 was 35.7 million yuan.

Admedus receives clearance for Vascucel in U.S.

Sunday, 16 Oct 2016 06:33pm EDT

Admedus Ltd : Asx alert-fda clearance granted for Vascucel-ahz.ax .Has received FDA 510(K) clearance to market Vascucel TM in US.

Ningbo David Medical Device sees 2016 9-mth net profit up 25 pct to 45 pct

Thursday, 13 Oct 2016 11:05pm EDT

Ningbo David Medical Device Co., Ltd.<300314.SZ>: Sees net profit for 2016 Q1-Q3 to increase by 25 percent to 45 percent, or to be 44.7 million yuan to 51.8 million yuan . Says the net profit of 2015 Q1-Q3 was 35.7 million yuan .Comments that increase in the main business is the main reason for the forecast.

Safe Orthopaedics 9M revenue down 11% to 1.7 million euros

Thursday, 13 Oct 2016 12:27pm EDT

Safe Orthopaedics SA :9 months revenue 1.7 million euros ($1.9 million) versus 1.9 million euros a year ago.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary